• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Medtronic Europe Sarl Cobalt¿ XT HF Quad CRT-D MRI SureScan¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Medtronic Europe Sarl Cobalt¿ XT HF Quad CRT-D MRI SureScan¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTPA2QQ
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Purulent Discharge (1812); Unspecified Infection (1930)
Date of Event 09/01/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that approximately one month post replacement procedure, the patient developed a pocket infection.It was noted that the patient developed purulent discharge/pus.The cardiac resynchronization therapy defibrillator (crt-d) system was explanted and replaced with a leadless implantable pulse generator (ipg).No further patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Continuation of d10: 439888 lead; 6935m62 lead implanted: (b)(6) 2026: 503da22 mechanical valve implanted: (b)(6) 2008.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Cobalt¿ XT HF Quad CRT-D MRI SureScan¿
Common Device Name
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
Medtronic Europe Sarl
route du molliau 31
case postale
tolochenaz vaud 1131
SZ  1131
Manufacturer (Section G)
Medtronic Europe Sarl
route du molliau 31
case postale
tolochenaz vaud 1131
SZ   1131
Manufacturer Contact
gerard torenvliet
8200 coral sea st ne
mounds view, MN 55112--439
+1(763)526-9277
MDR Report Key50877036
Report Number9614453-2026-03841
Device Sequence Number13089843
Product Code NIK
UDI-Device Identifier00763000178093
UDI-Public(01)00763000178093(17)271214(20)02
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P010031
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Device Explanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberDTPA2QQ
Device Catalogue NumberDTPA2QQ
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer09/09/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/01/2026
Initial Report FDA Received Date09/24/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/22/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
5076-52 LEAD.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age78 YR
Patient SexMale
-
-